Insight

Dec 20, 2024, 13:52

Biosimilars offer innovative treatment options for cancer care – UICC

Union for International Cancer Control (UICC) posted the following on LinkedIn:

“Biosimilars may be the key to expanding treatment options for cancer patients worldwide. But what are they, and how do they work? Discover the science behind these innovative therapies and their potential to reshape cancer care.

Watch this insightful content, produced with the support of Celltrion Inc., as part of the Rewriting Cancer series produced by BBC StoryWorks and presented by the Union for International Cancer Control (UICC).”

BBC StoryWorks biosimilars cancer cancer innovation cancer treatment Celltrion Inc. global oncology innovative therapies OncoDaily Oncology patient care Rewriting Cancer series UICC

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer